Mateon announced peer reviewed publication on its R&D effort against COVID-19
On Apr. 30, 2020, Mateon Therapeutics reported several peer-reviewed publications derived from its R&D effort against COVID-19. Published…
Nature publication presents new ‘Blueprint’ revealed how SARS-CoV-2 virus hijacks human cells
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
Biotechnology | COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics
Emory University launched study on COVID-19 immune responses
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
Just – Evotec Biologics collaborated with Ology Bioservices on antibodies against Coronavirus
On Apr. 30, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into a…
NIH clinical trial shows remdesivir accelerated recovery from advanced COVID-19
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
Clinical trial began to see if convalescent plasma can treat COVID-19
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
Windtree announced first patient enrolled in AEROSURF bridging study for treatment of Respiratory Distress Syndrome
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Entos Pharmaceuticals partnered with EpiVax to develop a pan-Coronavirus DNA vaccine
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
Illumina’s donation to Africa Centre for Disease Control expanded capability for sequencing-based COVID-19 surveillance
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
Secarna Pharma entered into cooperation with Guangzhou’s Sun Yat-sen University to develop treatment for SARS-CoV-2 viral infections
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
Sarepta Therapeutics announced research agreement with U.S. DoD to evaluate multiple constructs from proprietary RNA platform as treatments for COVID-19
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
INOVIO and GeneOne reported positive phase 1/2a clinical data with DNA vaccine INO-4700 for MERS Coronavirus
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase…
Six COVID-19 patients treated with RedHills opaganib under compassionate use show objective clinical improvement
On Apr. 27, 2020, RedHill Biopharma provided an additional update on the compassionate use program with its investigational…
Mateon announced filing of IND with FDA to evaluate antisense drug candidate OT-101 in COVID-19 patients
On Apr. 27, 2020, Mateon Therapeutics announced announced it has submitted an Investigational New Drug application to the…
Neurocrine Biosciences announced FDA approval of ONGENTYS as treatment for patients with Parkinson’s Disease
On Apr. 27, 2020, Neurocrine Biosciences announced the FDA approved once-daily oral ONGENTYS (opicapone) 25 mg and 50…
Edwards HemoSphere platform receives expanded use indication from Health Canada in treatment of COVID-19 patients
On Apr. 27, 2020, Edwards Lifesciences announced that Health Canada approved an expanded indication for use of the…
Regeneron and Sanofi updated phase 2/3 adaptive-designed trial of Kevzara (sarilumab) in hospitalized COVID-19 patients
On Apr. 27, 2020, Regeneron and Sanofi announced preliminary results from the Phase 2 portion of an ongoing…
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
iBio estimated 500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility
On Apr. 27, 2020, iBio announced it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL),…
Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
CTI Biopharma announced initiation of phase 3 PRE-VENT study evaluating Pacritinib in hospitalized patients with severe COVID-19
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
Atossa Therapeutics contracted with NYC Health + Hospitals/Metropolitan for COVID-19 HOPE clinical study
On Apr. 27, 2020, Atossa Therapeutics announced that it had contracted with NYC Health + Hospitals/Metropolitan in New…
FDA warned of ‘Off-Label’ use of antimalarial drugs hydroxychloroquine and chloroquine to treat COVID-19 patients
On Apr. 24, 2020 the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication regarding known…
Mesoblast reported 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
Global study to assess effects of COVID-19 in pregnancy on mothers and babies was launched
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
CIRM Board funded first clinical study for COVID-19
On Apr. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $749,999 to…
Keck Foundation gifted $4 million to USC to speed public health and research on COVID-19
On Apr. 24, 2020, the W. M. Keck Foundation announced a $4 million gift that will help scientists…
ViralClear submits investigational New Drug Application to FDA for phase II clinical trials for merimepodib
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear had submitted an Investigational New Drug (IND) application…
Oxford University COVID-19 vaccine began human trial stage
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…